The arterial hypotension that follows the start of cardiopulmonary bypass (CPB) has traditionally been attributed to decreased systemic vascular resistance (SVR), but no major tissue group where this decrease develops has been identified. Skeletal muscle approximates 40 percent of perfused body tissue by weight;' thus, an increase in muscle blood flow (MBF) or a decrease in muscle vascular resistance (MVR) could account for a large decrease in SVR. The direct dependence of the mean arterial pressure (MAP) on SVR and cardiac output (CO), or blood flow, suggests that in order to maintain a steady MAP when the SVR falls the CO should increase proportionately. Therefore, if for any reason the CO is limited during CPB or at its conclusion and the MVR 
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Reprint requests: Dr. Pauca Core and skin (Mallinckrodt) temperatures were measured rectally and on the distal part of the forearm under study. Blood temperature was measured in the pulmonary artery before and after CPB and in the blood returning to the oxygenator during CPB.
Radial pressure was measured through a 5-cm, 20-gauge catheter made of synthetic fluorine-containing resins (Teflon) attached to a 91-cm long, high-pressure tube, and a transducer (model T36AD-R; Spectromed, Inc., Oxnard, Calif). The system was calibrated statically to a mercury standard, and its natural frequency and damping coefficient were determined after each comparison by the flush method. 2 No vasodilator or vasopressor support was used except phenylephrine, 50 Ag/min, or less during normothermic CPB in two and after cessation of CPB in three patients. The FBF was measured by a mercury-in-rubber strain-gauge on the mid-forearm.3'4
The pressure of the venous occlusion cuff, placed above the elbow, was set at 20 mm Hg below the prevalent radial MAP. This was done after the circulation to the hand had been excluded at the Using repeated measures analysis of variance, we tested MAP, FBF, FVR, SVR, CI, blood temperature, skin temperature, hematocrit level, PaCO2, PaO2, pH, and serum potassium value for significant (p<0.05) variability during the surgical phases of CPB (pre-CPB, cold-CPB, normothermic-CPB, and post-CPB). When a significant difference for any of these variables was found, contrasts were performed to determine in which surgical phases the values were different from the pre-CPB baseline. The contrasts' alpha (probability values) levels were adjusted for multiple comparisons using the Bonferroni method. The effect of the aforementioned variables on FBF and FVR was tested using a repeated measures analysis of variance design with the covariate values changing with each surgical phase. The covariates were tested singly, as a group, and in combinations formed by stepwise elimination of the least significant covariates. Covariates tested were MAP, blood temperature, skin temperature, hematocrit level, PaCO2, and SVR. We also tested for associations between combinations of the previously noted variables and FBF or FVR using multivariate (canonical) correlation analysis with adjustments for the surgical phase. All results are expressed as mean +SEM.
RESULTS
There were 25 male and 2 female patients, 62 ± 1.5 years of age, and the frequency response and damping coefficient of the blood pressure measuring system were 23 ± 0.6 and 0.3 ± 0.0 Hz, respectively. The MAP decreased significantly (p<0.001) during both periods of bypass and the postbypass period ( Table 1 ). The FBF was 1.6±0.1 mmol/100 mmol tissue/min during the prebypass period and increased slightly to 1.8±0.1 during cold bypass, and to 3.7 ±0.3 and 3.6 ±0.3 during the warm and the postbypass periods, respectively. The PaCO2 (uncorrected for body temperature), PaO2, and pH were similar during the four study periods. Rectal temperature remained within ± 0.7°C of the blood temperature except during cold-CPB when it was 31.2 ±0.1°C. The serum potassium level varied between 3.4 mEq/L during the prebypass period and 5.8 mEq/L during cold-CPB. It 
By repeated measures analysis of variance, it was found that MAP, FVR, SVR, blood temperature, skin temperature, and hematocrit value changed significantly (p<0.001) from the prebypass to the three subsequent periods, even when the probability value levels were adjusted for multiple comparisons (Bonferroni method). Similar changes were reached by FBF and CI only during the warm-CPB and the post-CPB periods; serum potassium levels were higher (p<O.OOl) in the cold-and post-CPB than in the pre-CPB periods. Although FBF increased by 12 percent during cold-CPB, it did not reach statistical significance. It reached 126 percent and 121 percent, respectively, during normothermic-and post-CPB, respectively. For the whole group, both FVR and SVR changed in the same direction from the pre-CPB to the post-CPB phase; however, FVR decreased proportionately more than SVR: 31 vs 17 percent, 66 vs 47 percent, and 59 vs 33 percent during cold-, normothermic-, and the post-CPB periods. Additionally, the changes in FVR and SVR during progression from one surgical phase to the next offer some contrasts. Most tested (blood temperature, skin temperature, hematocrit level, PaCO2, serum potassium value, and SVR) had an effect on either FBF or FVR when tested singly or in combination. When the Bonferroni correction for multiple comparisons was applied, the lowest probability value became greater than 0.25. Using multivariate (canonical) correlation analysis, we found no significant correlations between combinations of covariates and FBF or FVR after adjustments for the surgical phase of the study. Two patients who were receiving phenylephrine during warm-CPB showed lower FBFs at this stage than during the post-CPB when they were not receiving phenylephrine; however, their respective low flows were 2.3 and 3.0 ml/100 ml of tissue/min, while 4 patients who were not receiving phenylephrine had even lower flows ranging from 1.6 to 2.0 ml/100 ml/min. The three patients receiving phenylephrine during the post-CPB period showed lower flows during this period than during the warm-CPB period. However, the decreases in relation to the previous period ranged from 17 to 36 percent, while patients receiving no phenylephrine showed similar decreases (17 to 48 percent). The range of FBFs at this stage was 1.8 to 4.0 ml/100 ml of tissue/min for patients receiving phenylephrine and from 1.8 to 5.9 ml/100 ml of tissue/min in those not receiving phenylephrine. Thus, it seems that phenylephrine at the doses used had no visible effect on FBF.
DISCUSSION
The decrease in FVR found in this study during CPB was significant. However, the FVR or ratio of radial MAP to FBF (an arbitrary but accepted way to express this variable3-5'713 is 18 to 30 in awake, unstressed subjects) in the control readings was 3 times higher in these patients than in awake subjects.4'7"1' This ratio decreased from 59 to 41 during cold bypass and to 20 and 24 during warm and the postbypass periods. Thus, FVR decreased during the first part of bypass, reaching a normal level only during warm and the postbypass periods. Stern et al14 reported a lower FVR at discontinuation of CPB in relation to that before CPB. Unfortunately, these authors did not report the FBF in milliliters per 100 ml of tissue per minute, nor did they give the FVR as the ratio of MAP to the FBF. They only stated their findings as a percent decrease in FVR from the preto the post-CPB state; thus, we do not know if they found a real decrease in FVR or only a recovery toward normal. Lazenby et al15 found, in dogs anesthetized with isofluorane, that blood flow in the femoral arteries increased significantly during hypothermic-CPB, while it decreased in other vascular beds (mesenteric, renal, etc.). These authors conclude that hypothermic-CPB increased MBF and decreased MVR. It is difficult to isolate the increase in MBF that these authors found from that produced by isoflurane anesthesia itself.16
Whether the likely low MBF found before and during cold-CPB has any detectable metabolic effects is unlikely; the acid-base status of our patients was entirely PaCO2-dependent, with a neutral and unchanged base excess. Furthermore, it has been found in men, that muscle intracellular metabolism is well preserved during CPB, even in the presence of low perfusion pressure.17
Because the vasomotor control of skeletal muscle is uniform for all muscle groups,7 our findings would indicate that a decrease in vascular resistance toward normal, rather than below normal, had occurred in 40 percent of the total body mass. Thus, although it contributes to the prevalent decreased MAP seen during CPB, it does not seem to be the major factor in patients under the conditions of those studied.
In order to equitably evaluate the effect of CPB on FBF as measured in this study we have to address some factors that could undermine our conclusions: great care was taken to avoid such levels. (b) Inhalational anesthetics do not seem to affect MBF, although halothane decreases it, and isoflurane increases it; thus all were avoided. (c) Venous occlusion plethysmography has not been used in the presence of changing skin temperatures and during nonpulsatile blood flow. Therefore, we calibrated the straingauges on the forearm before each measurement, and we accepted as true blood flow slopes, only those with straight-line pitch for a minimum of 3 s, equivalent to the first 3 pulsations accepted when using this method in subjects with pulsatile flow.8 (d) Because any form of stress will alter MBF4,7 9 and these patients were under different degrees of stress from the moment they learned of the need to have these operations, we discarded the possibility of obtaining true control blood flows. The pre-CPB blood flows were taken as control values, speculating that CPB would affect them sufficiently for the changes to ceiving phenylephrine during warm-CPB, the FBF increased slightly when the infusion was discontinued, and in the three who began receiving the infusion in the post-CPB period, the FBF decreased slightly. However, the flow variability seen in these patients was well within that of those not so treated. This equivocal effect probably is due to the small doses given. (g) Reliable measurements of forearm or hand blood flow by venous-occlusion plethysmography requires that the tested arm be positioned at or above heart level with no interference to venous return and patient displacement be limited. If the flows are low, as they were in our study, patient displacement must be entirely avoided. Thus, the surgical procedure had to be interrupted for a few minutes every time a measurement was done. The side effect of this decision was the short duration of the observation periods. We also only analyzed flow traces in which all 8 tracings were within the 95 percent confidence interval of each sample.
The mild effect of CPB on MBF is not a surprise since FBF and FVR tend to remain stable in the presence of mild hypotension produced by thiopentone,13 propofol," nitrous oxide,13 methoxyflurane,21 and severe sepsis.22 In fact, halothane, while reducing MAP, increases FVR in patients4,12'13-23 and in dogs.24 Up to date, only isoflurane is known to decrease FVR significantly,'6 and sedation with meperidine is known to produce a moderate decrease. 12 The environment in which this clinical study was performed was unsuitable for establishing cause-effect relationships between changes in FBF and other assessed variables. The relationship, or rather the lack thereof, between the changes in FVR and SVR during the warm-post-CPB period illustrates the futility of trying to establish relationships by statistical methods. It seems that the small-vessel vascular system is too complex in its behavior to be analyzed during a clinical study. We should add to this observation the different ages of our patients and, very likely, the differing states of their vascular systems. However, examining the results in Table 1 , one can relate the moderate decrease in FVR during cold-CPB to the interaction between a low hematocrit value, which would decrease viscosity and improve flow, and moderate hypothermia, which would decrease flow. During the warm-and the post-CPB periods, the effect of hemodilution would be unopposed, favoring the greater increase in FBF seen then. However, we found no statistical hint of a cause-effect relationship. Other speculative relationships to consider include nonpulsatile flow whose effect on the local and systemic vasomotor response is unknown, the level of circulating cathecholamines, and other systemic25 and local vasoactive substances. 26 The cause of the low flows during the prebypass period is not obvious, and the only factors that could intuitively be associated with this finding are the blood temperature of 35.0 ± 0.10 C, although there was no statistical association, and full muscle relaxation by pancuronium, which deserves further investigation.
In summary, in a group of 27 patients undergoing narcotic-midazolam anesthesia and mild hypothermia (blood temperature, 35 ± 0.1°C), the FVR was found to be conspicuously low before exposure to CPB. Introduction of CPB decreased the SVR significantly, reaching levels comparable to those of awake unstressed men only during rewarming and in the first few minutes of the post-CPB period. Thus, a decrease in MVR plays a role in the reduction of SVR during the warm-and post-CPB periods. However, its importance is not clear, since it was found that the FBF did not really increase above normal values but recovered toward normal values during CPB and remained normal after discontinuation of bypass.
